A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metastasis Research

Background:

• Nm23-H1 acts as a metastasis suppressor gene, with its interaction with h-Prune influencing cancer progression.
• h-Prune is overexpressed in various tumors and binds Nm23-H1, suggesting a role in cancer.
• Previous studies indicate that blocking the Nm23-H1/h-Prune interaction with a competitive permeable peptide (CPP) reduces cancer cell migration.

Purpose of the Study:

• To investigate the anti-tumoral effect of impairing the Nm23-H1/h-Prune complex using CPP in a prostate cancer xenograft model.
• To evaluate CPP's potential as a therapeutic strategy for prostate cancer.

Main Methods:

• Utilized a mouse orthotopic xenograft model of prostate cancer.
• Employed bioluminescent imaging to track tumor progression and metastasis.
• Assessed the impact of CPP on AKT/mTOR and NF-kB signaling pathways and apoptosis.

Main Results:

• CPP significantly reduced prostate cancer metastasis formation in the xenograft model.
• CPP was shown to inhibit AKT/mTOR and NF-kB signaling pathways.
• CPP treatment also induced apoptosis in cancer cells.

Conclusions:

• Impairing the h-Prune/Nm23-H1 complex with CPP demonstrates anti-tumoral effects in prostate cancer.
• CPP holds promise as a potential therapeutic agent for treating prostate cancer by reducing metastasis.